MCLA-128, zenocutuzumab, Phase 1/2 eNRGy trial remains on trackMCLA-117 program update to be presented at upcoming medical meetingAnand Mehra, M.D. […]
Distributions from Tinuum total $17.1 million; Prioritizing cash and liquidity to navigate pandemic related business impactsGREENWOOD VILLAGE, Colo., May 11, […]
CAMBRIDGE, Mass., May 11, 2020 (GLOBE NEWSWIRE) — Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing curative […]
AUSTIN, Texas, May 11, 2020 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company […]